We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCY
12926
Oncolytics Biotech
ONCY
$99.2M
$81K ﹤0.01%
29,389
-19,989
-40% -$61.2K
WYY icon
12927
CALL
WidePoint Corp
WYY
$92M
$81K ﹤0.01%
11,200
+100
+0.9% +$787
AIOT
12928
CALL
PowerFleet Inc
AIOT
$415M
$81K ﹤0.01%
+11,300
New +$82.4K
NPKI
12929
PUT
NPK International
NPKI
$1.21B
$81K ﹤0.01%
23,400
+1,400
+6% +$4.75K
SIOX
12930
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$81K ﹤0.01%
29,800
+4,100
+16% +$10.2K
AXU
12931
CALL
DELISTED
Alexco Resource Corp
AXU
$81K ﹤0.01%
32,300
+18,100
+127% +$50.9K
LJPC
12932
DELISTED
La Jolla Pharmaceutical Company
LJPC
$81K ﹤0.01%
+18,967
New +$81.3K
ASMB icon
12933
CALL
Assembly Biosciences
ASMB
$629M
$80K ﹤0.01%
1,717
+25
+1% +$1.24K
MRAM icon
12934
Everspin Technologies
MRAM
$447M
$80K ﹤0.01%
+12,472
New +$71.4K
UTI icon
12935
CALL
Universal Technical Institute
UTI
$1.38B
$80K ﹤0.01%
+12,300
New +$72.6K
MAAS
12936
Maase Inc
MAAS
$7.3B
$80K ﹤0.01%
+247
New +$77K
AHPI
12937
DELISTED
Allied Healthcare Products
AHPI
$80K ﹤0.01%
19,263
-25,137
-57% -$107K
ADMS
12938
DELISTED
Adamas Pharmaceuticals
ADMS
$80K ﹤0.01%
15,127
-27,419
-64% -$142K
AVTX icon
12939
Avalo Therapeutics
AVTX
$1.04B
$79K ﹤0.01%
+8
New +$67K
ICMB icon
12940
Investcorp Credit Management BDC
ICMB
$11.8M
$79K ﹤0.01%
+14,361
New +$82.3K
SND icon
12941
CALL
Smart Sand
SND
$219M
$79K ﹤0.01%
23,800
-12,200
-34% -$31.9K
KBNT
12942
PUT
DELISTED
Kubient, Inc. Common Stock
KBNT
$79K ﹤0.01%
+13,900
New +$81K
HBP
12943
CALL
DELISTED
Huttig Building Products, Inc.
HBP
$79K ﹤0.01%
13,600
+100
+0.7% +$529
CLIR icon
12944
ClearSign Technologies
CLIR
$30M
$78K ﹤0.01%
+1,615
New +$76.4K
CRVS icon
12945
Corvus Pharmaceuticals
CRVS
$1.24B
$78K ﹤0.01%
29,278
-34,993
-54% -$96.3K
EGY icon
12946
Vaalco Energy
EGY
$605M
$78K ﹤0.01%
24,129
+3,638
+18% +$10K
EMX
12947
DELISTED
EMX Royalty
EMX
$78K ﹤0.01%
26,264
+871
+3% +$2.85K
LSAK icon
12948
CALL
Lesaka Technologies
LSAK
$406M
$78K ﹤0.01%
16,600
-4,900
-23% -$25.5K
MIN
12949
Aberdeen Intermediate Income Fund
MIN
$280M
$78K ﹤0.01%
20,724
-13,495
-39% -$49.9K
IMG
12950
DELISTED
CIMG Inc
IMG
$78K ﹤0.01%
+35
New +$78.6K

Similar funds

Citadel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Citadel Advisors held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Citadel Advisors's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Citadel Advisors's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Citadel Advisors added most to AT&T in Q2 2021, an estimated $877M increase.
  • Citadel Advisors's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Citadel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Citadel Advisors's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Citadel Advisors opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Citadel Advisors's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.